At just 19, while most of her peers were still navigating lecture halls and course outlines, Oluwamisimi Akinlolu was already confronting a problem that would come to define her life’s work.

At Covenant University, she built a diabetes management system that earned Best Innovative Health Project of the Year. It was, by all accounts, an early triumph. But the award was only the beginning of her epiphany into the silent woes bedevilling Nigeria’s healthcare system.

“The gap between health data and health decisions is not a technology problem,” she would later realize. “It is a design problem.” That insight has guided Akinlolu across the globe and disciplines, from Nigeria’s national immunization systems to the oncology division of a top global pharmaceutical company in the United States. Along the way, she has built analytics platforms used by government officials, mapped millions of unvaccinated children using geospatial models, and developed forecasting systems that shape how cancer drugs are planned and deployed.

Through all this time, her impact across the global health scene has evolved to tackle the reality of fragmented data, which she believes is the single reason decisions fail within the scene.

‘Baby Steps to Blooming Impact’
Akinlolu’s early career placed her directly inside the problem she had begun to articulate as a student. At eHealth4everyone, a Gates Foundation–supported organization, she confirmed her suspicions that within the Nigerian public health scene there was too much data, and not enough agreement on what it meant.

Facility reports, demographic surveys, population estimates, and partner datasets routinely produced conflicting figures for the same indicators in the same locations. For federal and state decision-makers, the question was no longer whether data existed, but which version of it to trust.

The scary part was not even the ambiguity; it was that planning continued regardless despite contradictions.

As principal architect of the Multi-Source Data Analytics and Triangulation platform (MSDAT), Akinlolu designed a system that reconciled these competing streams into a single, transparent view. By standardizing definitions and applying consistent rules across datasets, MSDAT allowed policymakers to see both the numbers, their sources and their contrasts.

The result was fruitful. Data usage among stakeholders rose, reporting accuracy improved, and the platform was adopted for immunization and primary healthcare planning across multiple levels of government. It validated her belief that with properly structured data, effective decision making was possible.

As Akinlolu’s trajectory evolved, she began to make a name for herself by mapping the invisible. At Sydani Group, one of Africa’s leading public health consulting organizations, her work expanded in both scale and urgency. Rising rapidly from intern to Senior Analyst, she became a central figure in Nigeria’s Zero-Dose Vaccination Strategy — a national effort targeting more than two million children who had never received a single vaccine.

However, her work also took its toll. How was she meant to find those unvaccinated children, despite Nigeria’s data gathering challenges? Traditional data systems could not accurately locate these children. They existed in the gaps: between surveys, beyond facility catchment areas, basically outside the reach of conventional reporting.

In response to this hurdle, Akinlolu designed a hybrid geospatial mapping model that combined satellite imagery, health facility data, population density estimates, and vaccination coverage indicators. The model identified where unvaccinated children might be and it also revealed communities that had been systematically missed.

It became the technical foundation for Nigeria’s national zero-dose strategy and contributed to securing major international funding support. At the same time, she expanded her gaze to find out why people were actually missing from the system.

‘Sustainable Solutions’
During the COVID-19 vaccination rollout, Akinlolu developed a social listening architecture that turned public sentiment into operational insight. Working directly within the Federal Ministry of Health and the National Primary Health Care Development Agency (NPHCDA), she was embedded inside the government’s response infrastructure — not advising from the outside, but shaping decisions alongside senior NPHCDA leadership and FMoH technical teams as they were being made.

Drawing from social media, community reports, and communication channels, the system used machine learning to detect patterns in how people spoke about vaccines received through the national programme, including their fears, doubts, and resistance.

The system allowed health teams to develop more targeted behavioural health communication strategies. It tackled vaccine hesitancy from the root: behavioural communication gaps, which stemmed from misinformation, structural barriers, and general distrust.

But what set Akinlolu’s contribution apart was the institutional architecture she built around the technology. She coordinated across the Advocacy, Communication, and Social Mobilization (ACSM) groups spanning all 36 states plus the Federal Capital Territory, developing a national communications toolkit and leading training for ACSM officers across the country. She supported the country’s Evidence Generation Task Team — ensuring that operational decisions during the COVID-19 response were grounded in current, triangulated, behaviorally informed data. She helped establish the COVID-19 Rapid Response Immunization and Communication Centre (CRICC) within the NPHCDA, a nerve center where social listening data, ACSM field reports, and vaccination operational data converged into coordinated, rapid-cycle communication decisions.

All of this was happening while she simultaneously supported the mass vaccination campaigns ramping up vaccine uptake across the country. The result: vaccine uptake increased by more than 55% during the period when the social listening system, the CRICC, and the ACSM coordination were all operating in concert.

In short, her efforts worked. Campaigns became more aligned with real concerns, and vaccination uptake improved in targeted populations. For the first time, the entire public health ministry realized that listening at scale was more important than just top-down broadcasting.

After transitioning to the United States, Akinlolu’s work and impact expanded. Her consulting roles in California and strategy work tied to large-scale funding initiatives was her first move. Shortly, she pursued an MBA at Johns Hopkins Carey Business School, where she focused on health, technology, and innovation. There, she explored questions that mirrored her earlier work in Nigeria: how data moves, how decisions are made, and where systems fail under complexity.

Her current role at a top global pharmaceutical company brings those questions into the high stakes world of oncology. As a data manager within the oncology business unit, she operates at the intersection of governance, analytics, and commercial strategy.

One of her key contributions has been the development of a Loss of Exclusivity forecasting framework — a model that integrates prescription trends, competitive intelligence, and market dynamics to predict how drugs perform as they lose patent protection. Like her earlier systems, it is less about prediction than about structure: ensuring that decisions are built on coherent, aligned data rather than fragmented inputs.

Across the organization, she has also led efforts to standardize data definitions, streamline reporting pipelines, and establish governance frameworks that reduce inconsistency. The result is not just cleaner data, but more reliable decisions.

‘The Future of Public Health: Decision Architecture As A Lifeline’
In her soft spoken manner, Akinlolu describes her discipline as decision architecture.

Her operations typically follow a simple sequence: identify where decisions are breaking down, integrate fragmented data into a unified view, standardize definitions and rules, embed the system into real workflows, and measure the outcome. “I don’t build tools for a single context,” she says. “I build systems that make decisions more reliable.”
Whether in Nigerian public health systems or global pharmaceutical strategy, the underlying problem — and its solution — remains the same.

Outside her formal roles, Akinlolu has contributed to global knowledge systems as a peer reviewer for leading journals and as a speaker on health communication and data systems. She has also invested in mentorship, creating initiatives that support emerging professionals navigating similar paths.

Akinlolu’s work was born from a reality she has seen firsthand. “I grew up in a system where decisions were made on inconsistent data. And I saw what that cost.” In many ways, her career has been an ongoing response to that observation.

Her life’s work is a sustained effort to close the gap between what data says and what decision makers do. At its core, it is about making better decisions possible. And in health systems, where decisions are often measured in lives, that difference is everything. It just very much is the lifeline of public health.

Oluwamisimi Akinlolu is an Oncology Business Unit Data Manager at a leading global pharmaceutical company. She operates at the highest level of health data decision-making, where analytics directly shape multi-million-dollar clinical and commercial strategies.